Global High Throughput Screening Market Growth (Status and Outlook) 2023-2029

Global High Throughput Screening Market Growth (Status and Outlook) 2023-2029

High-throughput screening (HTS) is a method for scientific experimentation especially used in drug discovery and relevant to the fields of biology and chemistry. Using robotics, data processing and control software, liquid handling devices, and sensitive detectors, High-Throughput Screening allows a researcher to quickly conduct millions of chemical, genetic or pharmacological tests.

LPI (LP Information)' newest research report, the “High Throughput Screening Industry Forecast” looks at past sales and reviews total world High Throughput Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected High Throughput Screening sales for 2023 through 2029. With High Throughput Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High Throughput Screening industry.

This Insight Report provides a comprehensive analysis of the global High Throughput Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High Throughput Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High Throughput Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High Throughput Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High Throughput Screening.

The global High Throughput Screening market size is projected to grow from US$ 11750 million in 2022 to US$ 15940 million in 2029; it is expected to grow at a CAGR of 4.5% from 2023 to 2029.

Based on technology, the label-free technology segment is expected to grow at the highest CAGR during the forecast period. The major advantage offered by label-free technology is that it can help in the study of varied cell types and targets. Label-free assays also provide simple methods for studying complex biological pathways. The label-free technology is set to reduce drug failure caused by toxicity. These factors are likely to boost the growth of this technology market.

This report presents a comprehensive overview, market shares, and growth opportunities of High Throughput Screening market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Cell-based Assays
Lab-On-A-Chip
Ultra-High-Throughput Screening
Bioinformatics
Label-Free Technology

Segmentation by application
Pharmaceutical and Biotechnology Companies
Academic and Government Institutes
Contract Research Organizations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Agilent Technologies
Danaher
Perkinelmer
Tecan Group
Axxam
Bio-Rad Laboratories
Merck
Hamilton
Corning Incorporated
Biotek Instruments
Aurora Biomed

Please note: The report will take approximately 2 business days to prepare and deliver.